Company: ZCARW
Filing Date: 2025-03-04
Form Type: S-1
Source: 0001213900-25-020176
Chunk: 240

Company: Zoomcar Holdings, Inc.
Filing Date: 2025-03-04
Form: S-1
Chunk 240
---
 named in such warrants itself. If holders of Company’s Common Stock are given a choice as to the securities, cash or property to be received in a Fundamental Transaction, then the holder shall be given the same choice as to the consideration it receives upon any exercise of such warrants following such Fundamental Transaction. A holder of December Series B Warrants does not have the right to exercise any portion of the December Series B Warrants if the holder (together with its affiliates) would beneficially own in excess of 4.99% of the number of shares of the Company’s Common Stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the December Series B Warrants. However, any holder may increase or decrease such percentage to any other percentage not in excess of 9.99%, provided that any increase in such percentage shall not be effective until 61 days following notice from the holder to the Company. The December Series B Warrants contain a standard cashless exercise provision permitting the holder to exercise the December Series B Warrants on a cashless basis if the market price of the Company’s Common Stock at the time of exercise is in excess of the exercise price of the December Series B Warrants and there is not an effective resale registration statement available for the resale of the shares of Common Stock underlying the December Series B Warrants. January/February Series A Warrants The terms of the January/February Series A Warrants are identical to the terms of the December Series A Warrants. January/February Series B Warrants The terms of the January/February Series B Warrants are identical to the terms of the December Series B Warrants. Placement Agent Warrants See “ Private Placement” for information on the warrants issued to the Placement Agent. 153 Authorized but Unissued Capital Stock Delaware law does not require stockholder approval for any issuance of authorized shares. However, the listing requirements of Nasdaq, which will apply so long as the shares of Common Stock remain listed on Nasdaq, require stockholder approval of certain issuances of Common Stock (including any securities convertible into Common Stock) equal to or exceeding 20% of the then outstanding voting power or the then outstanding number of shares of Common Stock. These additional shares may be used for a variety of corporate purposes, including future public offerings, to raise additional capital or to facilitate acquisitions. One of the effects of the existence of unissued and unreserved Common Stock or preferred stock may be to enable our Board to issue shares to persons friendly to current management,